These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 17438102
1. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth. Carrillo J, García-Aragoncillo E, Azorín D, Agra N, Sastre A, González-Mediero I, García-Miguel P, Pestaña A, Gallego S, Segura D, Alonso J. Clin Cancer Res; 2007 Apr 15; 13(8):2429-40. PubMed ID: 17438102 [Abstract] [Full Text] [Related]
2. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. García-Aragoncillo E, Carrillo J, Lalli E, Agra N, Gómez-López G, Pestaña A, Alonso J. Oncogene; 2008 Oct 09; 27(46):6034-43. PubMed ID: 18591936 [Abstract] [Full Text] [Related]
3. Mesenchymal stem cell features of Ewing tumors. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O. Cancer Cell; 2007 May 09; 11(5):421-9. PubMed ID: 17482132 [Abstract] [Full Text] [Related]
4. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription. Navarro D, Agra N, Pestaña A, Alonso J, González-Sancho JM. Carcinogenesis; 2010 Mar 09; 31(3):394-401. PubMed ID: 20019092 [Abstract] [Full Text] [Related]
5. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ. Cancer Res; 2005 Jun 01; 65(11):4633-44. PubMed ID: 15930281 [Abstract] [Full Text] [Related]
6. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y. J Clin Invest; 1997 Jan 15; 99(2):239-47. PubMed ID: 9005992 [Abstract] [Full Text] [Related]
7. Procholecystokinin as marker of human Ewing sarcomas. Reubi JC, Koefoed P, Hansen Tv, Stauffer E, Rauch D, Nielsen FC, Rehfeld JF. Clin Cancer Res; 2004 Aug 15; 10(16):5523-30. PubMed ID: 15328192 [Abstract] [Full Text] [Related]
8. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group. Stegmaier S, Leuschner I, Aakcha-Rudel E, Münch P, Kazanowska B, Bekassy A, Treuner J, Koscielniak E. Klin Padiatr; 2004 Aug 15; 216(6):315-22. PubMed ID: 15565546 [Abstract] [Full Text] [Related]
9. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Mendiola M, Carrillo J, García E, Lalli E, Hernández T, de Alava E, Tirode F, Delattre O, García-Miguel P, López-Barea F, Pestaña A, Alonso J. Int J Cancer; 2006 Mar 15; 118(6):1381-9. PubMed ID: 16206264 [Abstract] [Full Text] [Related]
10. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ. Nat Genet; 1999 Oct 15; 23(2):222-7. PubMed ID: 10508522 [Abstract] [Full Text] [Related]
11. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Watanabe G, Nishimori H, Irifune H, Sasaki Y, Ishida S, Zembutsu H, Tanaka T, Kawaguchi S, Wada T, Hata J, Kusakabe M, Yoshida K, Nakamura Y, Tokino T. Genes Chromosomes Cancer; 2003 Mar 15; 36(3):224-32. PubMed ID: 12557222 [Abstract] [Full Text] [Related]
12. EWS-Fli1 up-regulates expression of the Aurora A and Aurora B kinases. Wakahara K, Ohno T, Kimura M, Masuda T, Nozawa S, Dohjima T, Yamamoto T, Nagano A, Kawai G, Matsuhashi A, Saitoh M, Takigami I, Okano Y, Shimizu K. Mol Cancer Res; 2008 Dec 15; 6(12):1937-45. PubMed ID: 19074838 [Abstract] [Full Text] [Related]
13. EWS-FLI1 inhibits TNFalpha-induced NFkappaB-dependent transcription in Ewing sarcoma cells. Lagirand-Cantaloube J, Laud K, Lilienbaum A, Tirode F, Delattre O, Auclair C, Kryszke MH. Biochem Biophys Res Commun; 2010 Sep 03; 399(4):705-10. PubMed ID: 20691659 [Abstract] [Full Text] [Related]
14. The possible role of EWS-Fli1 in evasion of senescence in Ewing family tumors. Matsunobu T, Tanaka K, Nakamura T, Nakatani F, Sakimura R, Hanada M, Li X, Okada T, Oda Y, Tsuneyoshi M, Iwamoto Y. Cancer Res; 2006 Jan 15; 66(2):803-11. PubMed ID: 16424012 [Abstract] [Full Text] [Related]
15. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Staege MS, Hutter C, Neumann I, Foja S, Hattenhorst UE, Hansen G, Afar D, Burdach SE. Cancer Res; 2004 Nov 15; 64(22):8213-21. PubMed ID: 15548687 [Abstract] [Full Text] [Related]
16. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria RL. Cancer Res; 2005 Oct 01; 65(19):8698-705. PubMed ID: 16204038 [Abstract] [Full Text] [Related]
17. EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin. Siligan C, Ban J, Bachmaier R, Spahn L, Kreppel M, Schaefer KL, Poremba C, Aryee DN, Kovar H. Oncogene; 2005 Apr 07; 24(15):2512-24. PubMed ID: 15735734 [Abstract] [Full Text] [Related]
18. STAT3 is activated in a subset of the Ewing sarcoma family of tumours. Lai R, Navid F, Rodriguez-Galindo C, Liu T, Fuller CE, Ganti R, Dien J, Dalton J, Billups C, Khoury JD. J Pathol; 2006 Apr 07; 208(5):624-32. PubMed ID: 16463269 [Abstract] [Full Text] [Related]
19. The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells. Amsellem V, Kryszke MH, Hervy M, Subra F, Athman R, Leh H, Brachet-Ducos C, Auclair C. Exp Cell Res; 2005 Apr 01; 304(2):443-56. PubMed ID: 15748890 [Abstract] [Full Text] [Related]
20. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Nishimori H, Sasaki Y, Yoshida K, Irifune H, Zembutsu H, Tanaka T, Aoyama T, Hosaka T, Kawaguchi S, Wada T, Hata J, Toguchida J, Nakamura Y, Tokino T. Oncogene; 2002 Nov 28; 21(54):8302-9. PubMed ID: 12447693 [Abstract] [Full Text] [Related] Page: [Next] [New Search]